8-K: Oracle Appoints Cleveland Clinic CEO to Board
Director Appointment
Oracle Corporation announced the election of Dr. Tomislav Mihaljevic, CEO of Cleveland Clinic, to its Board of Directors, effective May 6, 2026.
Summary
- Oracle Corporation has elected Dr. Tomislav Mihaljevic to its Board of Directors, effective May 6, 2026.
- The size of the Board has been increased to 13 members.
- Dr. Mihaljevic is the current Chief Executive Officer and President of Cleveland Clinic.
- He has extensive experience in managing complex healthcare organizations and expanding access to healthcare.
- Dr. Mihaljevic previously served as director of GE HealthCare.
- He will receive restricted stock units and standard cash compensation for non-employee directors.
- His appointment is intended to leverage his expertise at the intersection of healthcare, technology, and risk management.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive development, indicating strategic board expansion with a highly qualified individual relevant to Oracle's business objectives.
Positives
- Appointment of a highly experienced healthcare executive, Dr. Tomislav Mihaljevic, to the Board.
- Expansion of the Board to 13 members, potentially bringing diverse perspectives.
- Dr. Mihaljevic's background in managing complex clinical organizations and global healthcare systems is seen as valuable.
- His experience is expected to be beneficial in Oracle's efforts to help healthcare organizations leverage technology for improved patient and provider outcomes.
- His expertise in risk management is also highlighted as a benefit.
Risks
- Forward-looking statements are subject to material risks and uncertainties, as detailed in Oracle's SEC filings (Form 10-K and 10-Q).
Future Outlook
Statements relating to Oracle's future plans, expectations, beliefs, intentions, and prospects are forward-looking and subject to risks and uncertainties. Specific financial guidance is not provided in this filing.
Management Comments
- "Tom is one of the worlds leading healthcare executives, with deep experience managing complex clinical organizations, advancing patient care, and expanding access to high-quality healthcare around the world," said Mike Sicilia, Oracle Chief Executive Officer.
- "Toms perspective will be invaluable as Oracle continues to help healthcare organizations use technology to improve outcomes for patients and providers."
- "Toms leadership at Cleveland Clinic gives him a unique understanding of the challenges facing healthcare systems globally. Oracle, along with its customers and shareholders, will benefit from Toms experience at the intersection of healthcare, technology and risk management," said Bruce Chizen, Chair of Oracles Nomination and Governance Committee.
Industry Context
StockSavvy.ai notes that Oracle's strategic appointment of a prominent healthcare CEO to its board signals a continued focus on leveraging its technology solutions within the healthcare sector, a key growth area for enterprise software companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | Tomislav Mihaljevic | 2026-05-06 | Election to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size Increase | The size of the Board of Directors was increased to 13 members. | 2026-05-06 | Potentially enhances board diversity and oversight capacity. |
| Director Compensation | Dr. Mihaljevic will receive restricted stock units and standard cash compensation for non-employee directors. | 2026-05-31 | Standard compensation practice for non-employee directors, aligning incentives. |
Related Party Transactions
- Dr. Mihaljevic has no reportable related party transactions with Oracle under Item 404(a) of Regulation S-K.
Stakeholder Impact
- Shareholders: Potential for enhanced board oversight and strategic direction due to the addition of an experienced executive.
- Employees: Indirect impact through potential improvements in company strategy and performance.
- Customers: Potential for improved technology solutions in the healthcare sector, benefiting from Dr. Mihaljevic's industry insights.
Next Steps
- Dr. Mihaljevic will be granted restricted stock units on May 31, 2026.
- The RSUs will fully vest on the first anniversary of the grant date, provided Dr. Mihaljevic continues to serve as a director.
- Directors will next stand for election at the company's annual meeting of stockholders in November 2026.
Key Dates
| Date | Description |
|---|---|
| 2004-01-01T00:00:00.000Z | Dr. Mihaljevic joined Cleveland Clinic as a surgeon. |
| 2015-01-01T00:00:00.000Z | Dr. Mihaljevic began serving as CEO of Cleveland Clinic Abu Dhabi. |
| 2018-01-01T00:00:00.000Z | Dr. Mihaljevic became CEO of Cleveland Clinic. |
| 2026-05-06T00:00:00.000Z | Effective date of Dr. Mihaljevic's election to the Board of Directors. |
| 2026-05-12T00:00:00.000Z | Date of the press release announcing the appointment and the filing of the Form 8-K. |
| 2026-05-31T00:00:00.000Z | Date for the grant of restricted stock units to Dr. Mihaljevic. |
| 2026-11-01T00:00:00.000Z | Oracle's annual meeting of stockholders where directors will next stand for election. |
Keywords
Oracle Corporation, Board of Directors, Tomislav Mihaljevic, Cleveland Clinic, Healthcare Executive, Corporate Governance, Director Appointment, GE HealthCare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.